|
Market Closed -
Bombay S.E.
14:02:22 21/08/2026 +04
|
5-day change | 1st Jan Change | ||
| 417.70 INR | +0.87% |
|
+0.16% | +1.42% |
| 08-03 | Aarti Drugs Limited, Q1 2027 Earnings Call, Aug 03, 2026 | |
| 07-31 | Aarti Drugs Limited Announces Management Changes | CI |
| Market Cap | 38.12B 398M 341M 319M 292M 549M 556M 3.77B 1.47B 19.15B 1.5B 1.46B 63.34B | P/E 2026 |
15x | P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 38.12B 398M 341M 319M 292M 549M 556M 3.77B 1.47B 19.15B 1.5B 1.46B 63.34B | EV / Sales 2026 |
1.14x | EV / Sales 2027 * | 1.29x |
| Free-Float |
40.44% | Yield 2026 * |
0.96% | Yield 2027 * | 1.41% |
Last Transcript: Aarti Drugs Limited
| 28/12/22 | Aarti Drugs : Loss of Share Certificates | PU |
| 10/07/22 | Aarti Drugs : Newspaper Advertisements | PU |
| 1 day | +0.87% | ||
| 1 week | +0.16% | ||
| Current month | -1.37% | ||
| 1 month | +1.25% | ||
| 3 months | +7.24% | ||
| 6 months | +12.09% | ||
| Current year | +1.42% |
| 1 week | 406.85 |  | 420.6 |
| 1 month | 401.25 | | 453.2 |
| Current year | 318.6 | | 453.2 |
| 1 year | 318.6 | | 534.15 |
| 3 years | 312.5 | | 634.9 |
| 5 years | 310.8 | | 648 |
| 10 years | 104.82 | | 1,025 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 80 | - | |
| Chief Executive Officer | 79 | 01/06/2007 | |
Adhish P. Patil
DFI | Director of Finance/CFO | 43 | 06/07/2012 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 79 | 01/04/2014 | |
| Director/Board Member | 62 | 01/06/2007 | |
| Chairman | 80 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.87% | +0.16% | -13.48% | -27.09% | 398M | |
| +0.88% | +6.38% | +76.40% | +126.75% | 1,119B | |
| +1.07% | +3.80% | +50.73% | +62.78% | 651B | |
| +1.20% | +6.21% | +25.81% | +78.74% | 468B | |
| +1.02% | +5.77% | +43.63% | +48.43% | 374B | |
| +0.85% | +4.07% | +24.97% | +40.58% | 302B | |
| +1.26% | +6.81% | +2.27% | +14.41% | 259B | |
| +1.88% | +5.81% | +49.57% | +70.53% | 238B | |
| +1.59% | +2.09% | -17.33% | -52.62% | 208B | |
| +1.87% | +5.61% | +27.32% | +91.38% | 181B | |
| Average | +1.25% | +4.17% | +26.99% | +45.39% | 380.03B | |
| Weighted average by Cap. | +1.14% | +5.09% | +44.25% | +72.64% |
| 2026 | 2027 * | |
|---|---|---|
| Net sales | 26.07B 272M 233M 218M 200M 375M 380M 2.58B 1.01B 13.09B 1.02B 1B 43.31B | 29.45B 308M 264M 247M 226M 424M 429M 2.91B 1.14B 14.8B 1.16B 1.13B 48.94B |
| Net income | 1.82B 19.04M 16.31M 15.26M 13.97M 26.22M 26.57M 180M 70.32M 915M 71.5M 69.95M 3.03B | 2.15B 22.49M 19.27M 18.03M 16.5M 30.97M 31.38M 213M 83.06M 1.08B 84.45M 82.62M 3.58B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 21/08/26 | ₹417.70 | +0.87% | 3,464 |
| 20/08/26 | ₹414.10 | +1.37% | 14,871 |
| 19/08/26 | ₹408.50 | -1.19% | 3,837 |
| 18/08/26 | ₹413.40 | +0.73% | 2,619 |
| 17/08/26 | ₹410.40 | -1.59% | 6,281 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Stocks
- AARTIDRUGS Stock
Select your edition
All financial news and data tailored to specific country editions
